• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Turning Point Therapeutics, Inc. - Common stock (NQ:TPTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 16, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 75.98 (9)
Ask (Size) 76.00 (7)
Prev. Close 76.01
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 50,074,277
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics
August 16, 2022
From Bristol Myers Squibb
Via Business Wire
News headline image
Blue Chip Stocks In Focus: Bristol-Myers Squibb ↗
August 15, 2022
The company has grown earnings by more than 20% per year on average over the last five and ten years. This explosive growth has enabled the company to continue growing its dividend. 
Via Talk Markets

Performance

More News

Read More
News headline image
Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗
July 27, 2022
Via Benzinga
News headline image
Analyst Ratings for Turning Point ↗
June 06, 2022
Via Benzinga
News headline image
Turning Point Secures Positive FDA Feedback For Planned Lung Cancer Drug Submission ↗
July 27, 2022
Via Benzinga
News headline image
The 3 Best Market Sectors for the Second Half of 2022 ↗
July 27, 2022
Via InvestorPlace
News headline image
TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders
July 05, 2022
From Halper Sadeh LLP
Via Business Wire
News headline image
TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX
July 05, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
UnitedHealth, Shockwave Lead 5 Healthy Stocks Breaking Out Or Setting Up ↗
June 25, 2022
Via Investor's Business Daily
News headline image
INVESTIGATION ALERT: Halper Sadeh LLP Investigates VMW, TPTX, CTT, CTEK
June 09, 2022
From Halper Sadeh LLP
Via AccessWire
News headline image
10 Biggest Price Target Changes For Monday ↗
June 06, 2022
Via Benzinga
News headline image
TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX
June 05, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
69 Biggest Movers From Friday ↗
June 06, 2022
Via Benzinga
News headline image
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More ↗
June 05, 2022
Via Benzinga
News headline image
The Acquisition of Turning Point Therapeutics By BMY- Bristol- Myers.
June 03, 2022
Via Best Stocks
News headline image
Mid-Afternoon Market Update: Gold Drops 1%; Sprague Resources Shares Spike Higher ↗
June 03, 2022
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
June 03, 2022
Via Benzinga
News headline image
Mid-Day Market Update: Nasdaq Down 300 Points; Turning Point Therapeutics Shares Jump ↗
June 03, 2022
Via Benzinga
News headline image
40 Stocks Moving In Friday's Mid-Day Session ↗
June 03, 2022
Via Benzinga
News headline image
TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders
June 03, 2022
From Halper Sadeh LLP
Via Business Wire
News headline image
CrowdStrike (CRWD) Stock Dips Despite Earnings Beat ↗
June 03, 2022
Via InvestorPlace
News headline image
TPTX Stock Soars 115% as Bristol Myers Announces Takeover of Turning Point Therapeutics ↗
June 03, 2022
Via InvestorPlace
News headline image
Mid-Morning Market Update: Markets Open Lower; US Economy Adds 390,000 Jobs In May ↗
June 03, 2022
Via Benzinga
News headline image
Bristol Myers Snaps Up Turning Point For $4.1 Billion In Cash — Is The Biotech Bear Dead? ↗
June 03, 2022
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
June 03, 2022
Via Benzinga

Frequently Asked Questions

Is Turning Point Therapeutics, Inc. - Common stock publicly traded?
Yes, Turning Point Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Turning Point Therapeutics, Inc. - Common stock trade on?
Turning Point Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Turning Point Therapeutics, Inc. - Common stock?
The ticker symbol for Turning Point Therapeutics, Inc. - Common stock is TPTX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap